The Latest Haemodialysis Journal Articles

Keep up to date with the latest in haemodialysis. Check out the latest haemodialysis articles from leading medical journals in a single view, helping you discover relevant articles quickly and easily

• Effect of reminiscence on cognitive impairment and depression in haemodialysis patients.10th January 2021
  Cognitive impairment and depression are common problems in haemodialysis patients.The present study was carried out to determine the impact of reminiscence on cognitive impairment and depression in haemodialysis patients.This clinical trial (2016) was conducted with a pretest-posttest design on the haemodialysis patients of hospitals in Shahrud, Iran.Block random sampling was used to investigate the patients’ […]
• Nurse’s practices and attitudes toward sexual health, wellbeing, and function in people receiving haemodialysis: A scoping review.10th January 2021
  Sexual health, wellbeing, and function are important parts of a person’s identity. Chronic diseases, such as kidney failure can alter, impair, and profoundly, affect sexual wellbeing and function.To conduct a scoping review of studies about renal nurses’ practice and attitudes towards sexual health, wellbeing, and function in people with kidney failure receiving haemodialysis.Using Arksey and […]
• Radiation dose from medical imaging in end stage renal disease patients: a Nationwide Italian Survey.2nd January 2021
  End stage renal disease (ESRD) patients are exposed to the risk of ionizing radiation during repeated imaging studies. The variability in diagnostic imaging policies and the accompanying radiation doses across various renal units is still unknown. We studied this variability at the centre level and quantified the associated radiation doses at the patient level.Fourteen Italian […]
• NT-pro-BNP as marker for cardiac strain that may be caused by high-output arteriovenous shunting in a haemodialysis patient. A case report.21st December 2020
  An arteriovenous fistula (AVF) is the first choice when considering access for haemodialysis (HD). When a forearm AVF fails an upper arm AVF is a frequent subsequent dialysis access option. The latter may cause cardiac strain. NT-pro-B-type natriuretic peptide (NT-NT-proBNP) is a marker used to estimate volume overload and cardiac strain. This case report shows […]
• Prevalence of malnutrition inflammation complex syndrome among patients on maintenance haemodialysis at Muhimbili National Hospital in Tanzania: a cross-sectional study.1st December 2020
  Malnutrition, inflammation, and the combination thereof are predictors of poor outcomes in haemodialysis patients. Malnutrition Inflammation Complex Syndrome (MICS) is an accelerator of atherosclerosis and portends high mortality. Early recognition and treatment of MICS may help to improve the clinical outlook of such patients. This study investigated the prevalence of MICS and its associated factors […]
• Changes to bone mineral density, the trabecular bone score and hip structural analysis following parathyroidectomy: a case report.27th November 2020
  Reduction in bone mineral density (BMD) measured by dual-energy X-ray absorptiometry (DXA) occurs in secondary hyperparathyroidism associated with chronic kidney disease. BMD generally increases following parathyroidectomy, however longitudinal changes to other DXA-derived parameters, the trabecular bone score (TBS) and hip structural analysis (HSA), have not been described. Postoperative calcium requirements and positive calcium balance raise […]
• Comparison of physical activity and quality of life in home haemodialysis (HHD) patients versus conventional in-centre haemodialysis (ICHD) patients: the observational, longitudinal, prospective, international, multicentric SeCoIA study protocol.23rd November 2020
  Home haemodialysis (HHD), has shown improved clinical outcomes, as well as a better quality of life, compared to conventional in-centre haemodialysis (ICHD) but still has a global low prevalence among end-stage renal disease patients. Haemodialysis (HD) patients tend to be sedentary but only few studies, mainly in North American ICHD patients, have evaluated the level […]
• A mixed-methods feasibility study of an arts-based intervention for patients receiving maintenance haemodialysis.20th November 2020
  Haemodialysis can negatively impact quality of life and mental health. Arts-based interventions used successfully in other settings to improve health and well-being, could help address the impact of haemodialysis. This study aimed to evaluate the feasibility and acceptability of conducting a randomised controlled trial (RCT) of an arts-based intervention for patients receiving haemodialysis.A parallel convergent […]
• Mycobacterium abscessus – an uncommon, but important cause of peritoneal dialysis-associated peritonitis – case report and literature review.18th November 2020
  Peritoneal dialysis (PD) is a form of therapy for end-stage kidney disease (ESKD), and peritonitis is a known complication. Mycobacterium (M) species associated peritonitis in PD patients is uncommon. Our experience of managing PD associated peritonitis caused by M abscessus in a middle-aged man with ESKD due to focal segmental glomerulosclerosis is shared in this […]
• Hepatitis C core antigen testing to diagnose active hepatitis C infection among haemodialysis patients.14th November 2020
  Hepatitis C virus (HCV) infects more than 71 million people worldwide and chronic HCV infection increases the risk of liver cirrhosis and failure. Haemodialysis (HD) is one of the renal replacement therapies with risk of HCV transmission. Anti-HCV antibodies are the serological screening test for HCV infection that does not detect active phase of infection. […]
• Nurse-led advance care planning with older people who have end-stage kidney disease: feasibility of a deferred entry randomised controlled trial incorporating an economic evaluation and mixed methods process evaluation (ACReDiT).14th November 2020
  Advance Care Planning is recommended for people with end-stage kidney disease but evidence is limited. Robust clinical trials are needed to investigate the impact of advance care planning in this population. There is little available data on cost-effectiveness to guide decision makers in allocating resources for advance care planning. Therefore we sought to determine the […]
• Ultrafiltration in critically ill patients treated with kidney replacement therapy.11th November 2020
  Management of fluid overload is one of the most challenging problems in the care of critically ill patients with oliguric acute kidney injury. Various clinical practice guidelines support fluid removal using ultrafiltration during kidney replacement therapy. However, ultrafiltration is associated with considerable risks. Emerging evidence from observational studies suggests that both slow and fast rates […]
• Precision medicine approach to dialysis including incremental and decremental dialysis regimens.6th November 2020
  Conventional standardization of haemodialysis for treatment of end-stage kidney disease (ESKD) is predicated upon the fixed construct of one disease stage and one patient category. Increasingly recognized are subgroups of patients for whom less-intensive haemodialysis, such as incremental or decremental haemodialysis, could be employed.Almost 30% of patients with incident ESKD have clinical and residual kidney […]
• The effect of protein-enriched snacks on serum albumin concentration in non-selected haemodialysis patients.2nd November 2020
  Serum albumin level is not only one of the protein-energy wasting criteria but also a powerful marker of mortality in patients on haemodialysis (HD) treatment. The study aimed to assess the effect of a protein-enriched snack given during HD treatment on serum albumin level.This prospective, single-centre, observational, non-randomized 16-month study was sub-divided into four 4-month […]
• Validation of the scale of assessment of self-care behaviours for arteriovenous fistula in patients ongoing haemodialysis in Turkey.2nd November 2020
  Several guidelines recommend that patients with chronic kidney disease treated by haemodialysis (HD) take care of their own arteriovenous fistula (AVF). The dialysis nurse plays an important role in the development of such self-care behaviours. A very small number of instruments are available to assess self-care behaviours with AVF in Turkey.Cultural adaptation and psychometric testing […]
• The work environment of haemodialysis nurses and its mediating role in burnout.28th October 2020
  The work environment can contribute to the occurrence of nurses’ burnout.This study assessed the work environment of haemodialysis nurses and the extent of burnout they have suffered, and it explored the connection between work environment and burnout.A multicentre cross-sectional study was conducted in 53 public, hospital-based haemodialysis units in Greece.A total of 537 haemodialysis nurses participated. […]
• Analysis of experience of the use of plastic cannulas in Spanish haemodialysis units.28th October 2020
  Plastic cannulas (PC) have shown efficacy in haemodialysis (HD) and are presented as a positive innovation for patients and vascular access survival.To analyse Spanish HD nurses’ experience of using PC.Cross-sectional observational study.An ad hoc questionnaire was administered on nurses’ experience of PC use.A total of 163 Spanish HD nurses were surveyed, of whom 42.3% had […]
• The lacking equation that estimates the protein catabolic rate in patients on once-weekly haemodialysis.27th October 2020
  The normalized protein catabolic rate (PCRn) is one of the key indices derived from the urea kinetic model (UKM) in haemodialysis (HD) patients. Ideally, it should be assessed using the double pool UKM (KDOQI clinical practice guidelines, AIKD, 2015), as the web-based software Solute-Solver (SS) does (Daugirdas et al., AJKD, 2009). Simple formulae exist to […]
• Health related quality of life among haemodialysis and kidney transplant recipients from Nepal: a cross sectional study using WHOQOL-BREF.13th October 2020
  Very less is known about health-related quality of life (HRQOL) among patients with kidney diseases in Nepal. This study examined HRQOL among haemodialysis and kidney transplant recipients in Nepal.The Nepali version of World Health Organization Quality of Life Instruments -(WHOQOL-BREF) questionnaire was administered using face to face interviews among end stage renal disease (ESRD) patients, […]
• Illness perceptions of Turkish Cypriot patients receiving haemodialysis: A qualitative study.10th October 2020
  Illness perceptions refer to cognitive appraisals that help patients understand and make sense of their condition. Although their importance in health behaviour and outcomes has been evidenced, less is known about cultural influences on mental representations of kidney failure amongst patients receiving haemodialysis in different settings.To explore the illness perceptions of Turkish patients receiving haemodialysis […]
• Development of a psychosocial intervention to support informal caregivers of people with end-stage kidney disease receiving haemodialysis.1st October 2020
  Patients with end-stage kidney disease, receiving haemodialysis rely increasingly on informal carers to help manage their debilitating chronic disease. Informal carers may experience a negative impact on their quality of life exacting a toll on their physical, social and emotional well-being. Informal carers of patients with end-stage kidney disease receiving haemodialysis have significant unmet needs […]
• COVID-19 in patients undergoing chronic kidney replacement therapy and kidney transplant recipients in Scotland: findings and experience from the Scottish renal registry.1st October 2020
  Infection with the severe acute respiratory coronavirus 2 (SARS-CoV-2) has led to a worldwide pandemic with coronavirus disease 2019 (COVID-19), the disease caused by SARS-CoV-2, overwhelming healthcare systems globally. Preliminary reports suggest a high incidence of infection and mortality with SARS-CoV-2 in patients receiving kidney replacement therapy (KRT). The aims of this study are to […]
• Shortened red blood cell age in patients with end-stage renal disease who were receiving haemodialysis: a cross-sectional study.30th September 2020
  The causes of anaemia in patients with end-stage renal disease include a relative deficiency in erythropoietin production and complex clinical conditions. We aimed to investigate the underlying mechanisms of anaemia in patients with end-stage renal disease who were undergoing maintenance dialysis by measuring erythrocyte creatine levels.In a cross-sectional study, we evaluated 69 patients with end-stage […]
• Left-sided heart disease and risk of death in patients with end-stage kidney disease receiving haemodialysis: an observational study.26th September 2020
  Cardiovascular disease is the most common cause of death in patients with end-stage kidney disease on haemodialysis. The potential clinical consequence of systematic echocardiographic assessment is however not clear. In an unselected, contemporary population of patients on maintenance haemodialysis we aimed to assess: the prevalence of structural and functional heart disease, the potential therapeutic consequences […]
• Getting the basics right: the monitoring of arteriovenous fistulae, a review of the evidence.5th September 2020
  Despite being the preferred vascular access for haemodialysis, the arteriovenous fistula (AVF) remains prone to a number of complications, the most common of these being thrombosis secondary to stenosis. This has resulted in the widespread use of monitoring and surveillance programmes. Surveillance uses more resources than monitoring and has not been convincingly shown to improve […]
• Volume management in haemodialysis patients.5th September 2020
  Accumulating evidence supports the important contribution of volume-related metrics to morbidity and mortality in patients receiving chronic haemodialysis. The purpose of this review is to summarize recent advances in the understanding and management of volume status in this high-risk group.Delivery of optimal volume management involves three key components: accurate estimation of volume status, correction of […]
• Risk factors for mortality in elderly haemodialysis patients: a systematic review and meta-analysis.2nd September 2020
  Older haemodialysis patients accompany a high burden of functional impairment, limited life expectancy, and healthcare utilization. This meta-analysis aimed to evaluate how various risk factors influenced the prognosis of haemodialysis patients in late life, which might contribute to decision making by patients and care providers.PubMed, Embase, and Cochrane Central were searched systematically for studies evaluating […]
• Outcomes of patients commencing peritoneal dialysis with and without back-up arteriovenous fistulas.28th August 2020
  Transitions from peritoneal dialysis (PD) to haemodialysis (HD) are often unpredictable and central venous catheters (CVCs) are frequently required. Early studies found few back-up arteriovenous fistulas (bAVFs) were ever used. The PD population’s characteristics have changed over time which may have altered the likelihood of bAVFs being used. This study aimed to report use of, […]
• Challenges and novel therapies for vascular access in haemodialysis.26th August 2020
  Advances in standards of care have extended the life expectancy of patients with kidney failure. However, options for chronic vascular access for haemodialysis – an essential part of kidney replacement therapy – have remained unchanged for decades. The high morbidity and mortality associated with current vascular access complications highlights an unmet clinical need for novel […]
• Protein energy-wasting associated with nephrotic syndrome – the comparison of metabolic pattern in severe nephrosis to different stages of chronic kidney disease.16th August 2020
  Nephrotic syndrome (NS) is associated with a hypercatabolic state expressed as an exacerbated degradation of muscle mass. However, the clinical significance of this phenomenon has not yet been investigated. The aim of the study was to evaluate the nutritional status of patients with severe NS (defined as nephrotic range proteinuria with hypoalbuminemia ≤2.5 g/dL) and estimated […]
• Metabolic syndrome in haemodialysis patients: prevalence, determinants and association to cardiovascular outcomes.15th August 2020
  In the general population, metabolic syndrome (MetS) is predictive of major adverse cardiovascular events (MACE). Waist circumference (WC), a component of the MetS criteria, is linked to visceral obesity, which in turn is associated with MACE. However, in haemodialysis (HD) patients, the association between MetS, WC and MACE is unclear.In a cross-sectional study of 1000 […]
• Impact on survival of urgent dialysis initiation in patients with end-stage renal disease: a case-control study.9th August 2020
  Outcomes of patients with end-stage renal disease at urgent dialysis initiation are varied, but evidence of their long-term prognosis is limited. We aimed to characterize patients undergoing urgent dialysis initiation and analyse its effect on survival outcome.We retrospectively identified 208 patients who began haemodialysis from 1 January 2012 to 31 December 2018 at our hospital. […]
• The current and future landscape of dialysis.1st August 2020
  The development of dialysis by early pioneers such as Willem Kolff and Belding Scribner set in motion several dramatic changes in the epidemiology, economics and ethical frameworks for the treatment of kidney failure. However, despite a rapid expansion in the provision of dialysis – particularly haemodialysis and most notably in high-income countries (HICs) – the […]
• Ultrafiltration rates and intradialytic hypotension: A case-control sampling of pooled haemodialysis data.31st July 2020
  Intradialytic hypotension (IDH) is one of the most critical adverse events during maintenance haemodialysis. Previous studies reported the association of fluid removal rate with the occurrence of IDH.We aimed to identify the optimal threshold of ultrafiltration rate to prevent the occurrence of IDH events. DESIGN, PARTICIPANTS AND MEASUREMENTS: Prognostic factor research with a retrospective case-control design […]
• Monitoring for intradialytic hypotension: An audit of nursing practice.30th July 2020
  Intradialytic hypotension (IDH) is one of the most common complications associated with haemodialysis (HD), yet the frequency of patient assessment by nurses varies in practice. We sought to measure the frequency of nursing assessments before, during and after HD and to identify any predictors of IDH.To audit the frequency, nursing management and contributing factors of […]
• Prevalence of foot disorders according to chronic kidney disease stage.30th July 2020
  Chronic kidney disease (CKD) is a public health disease that affects 15.1% of the adult population. Although a high prevalence (94.1%) of skin disorders has been detected in people on haemodialysis or with advanced CKD, few studies have analysed foot disorders at initial CKD stages.To analyse the prevalence of foot disorders according to CKD stage.A […]
• Use of proton pump inhibitors in dialysis patients: a double-edged sword?26th July 2020
  Large cohort-based studies have shown that proton pump inhibitors (PPIs) are linked to rare but multiple and varied secondary events when used in the general population. Although clinicians accept the negative effects of PPIs on renal function, there is a lack of available data regarding the potential consequences of their use by dialysis patients in […]
• Outcomes of arteriovenous access among cancer patients requiring chronic haemodialysis.25th July 2020
  There are limited data focusing specifically on the types of arteriovenous (AV) access used and outcomes of AV access among cancer patients as a consequence of cancer. We aimed to describe outcomes of AV access among cancer patients requiring chronic haemodialysis, and also to compare outcomes between patients with and without cancer.In this single-centre, retrospective, […]
• Towards personalized fluid monitoring in haemodialysis patients: thoracic bioimpedance signal shows strong correlation with fluid changes, a cohort study.13th July 2020
  Haemodialysis (HD) patients are burdened by frequent fluid shifts which amplify their comorbidities. Bioimpedance (bioZ) is a promising technique to monitor changes in fluid status. The aim of this study is to investigate if the thoracic bioZ signal can track fluid changes during a HD session.Prevalent patients from a single centre HD unit were monitored […]
• Persistent secondary hyperparathyroidism caused by parathyromatosis and supernumerary parathyroid glands in a patient on haemodialysis.8th July 2020
  Secondary hyperparathyroidism (SHPT) is a common high-risk factor for mortality in end-stage renal disease, and parathyromatosis and supernumerary parathyroid glands are very rare causes of persistent SHPT. Preoperative diagnosis and removal of all hyperplastic parathyroid glands are challenging. We report a rare case of persistent SHPT due to parathyromatosis and supernumerary parathyroid glands and successful […]
• Vascular access type and mortality in haemodialysis: a retrospective cohort study.18th June 2020
  Haemodialysis patients have a high mortality rate. Part of this can be attributed to vascular access complications. Large retrospective studies have shown a higher mortality in patients dialysed with a catheter, which is mostly ascribed to infectious complications. Since we observe very little infectious complications in our haemodialysis patients, the aim of our study was […]
• Minimum accelerometer wear-time for reliable estimates of physical activity and sedentary behaviour of people receiving haemodialysis.16th June 2020
  Low levels of physical activity are implicated in low life expectancies of people receiving maintenance haemodialysis. Accelerometers are increasingly being used to quantify activity behaviours of this population but guidance to quality-assure such data is lacking. The objective of this study was to provide data processing and reduction recommendations to ensure accelerometer-derived outcomes are sufficiently […]
• Hospitalization and mortality following non-attendance for hemodialysis according to dialysis day of the week: a European cohort study.11th June 2020
  The extension of the interdialytic interval due to due to dialysis session non-attendance varies according to which session of the week the patient misses. The impact of this on subsequent hospitalization and mortality is unknown.The ARO cohort study prospectively collected data from hemodialysis patients across 15 European countries on demography, comorbidity, laboratory, hospitalisation, mortality and […]
• Conversion of haemodialysis patients from iron sucrose to iron isomaltoside: a real-world experience.5th June 2020
  Anaemia is common in haemodialysis (HD) patients and associated with significant morbidity and mortality. Intravenous (IV) iron combined with erythropoiesis-stimulating agents (ESA) is the mainstay treatment of anaemia in these patients. The comparative efficacy and risk of adverse events with IV iron preparations have been assessed in only a few trials.This was a retrospective observational […]
• Present and future of kidney replacement therapy in Italy: the perspective from Italian Dialysis and Transplantation Registry (IDTR).24th May 2020
  Incidence of kidney replacement therapy (KRT) stabilizes or declines both in Europe and in the US; however, it is predictable that global prevalence of KRT will double by 2030. In this paper, we focus on the patterns of incidence, mortality, and prevalence of KRT in Italy, and we compare, when possible, the findings with other […]
• Establishing Core Cardiovascular Outcome Measures for Trials in Hemodialysis: Report of an International Consensus Workshop.17th May 2020
  Cardiovascular disease (CVD) affects more than two-thirds of patients receiving hemodialysis and is the leading cause of death in this population, yet CVD outcomes are infrequently and inconsistently reported in trials in patients receiving hemodialysis. As part of the Standardised Outcomes in Nephrology-Haemodialysis (SONG-HD) initiative, we convened a consensus workshop to discuss the potential use […]
• Association between extracellular volume control and survival in patients on short daily haemodialysis.1st May 2020
  Fluid overload (FO) assessed by bioimpedance spectroscopy (BIS) is associated with higher mortality risk in maintenance haemodialysis (HD). The aim was to assess if a better management of FO through short daily haemodialysis (SDHD) could improve survival.Retrospective analysis of patients who were on HD 3 sessions/week for at least 3 months and shifted to in-centre SDHD […]
• Oral health-related quality of life in adult patients with end-stage kidney diseases undergoing renal replacement therapy – a systematic review.1st May 2020
  The oral health of patients undergoing renal replacement therapy (RRT) is insufficient. Poor oral health and its components can affect the oral health-related quality of life (OHRQoL) of these patients. The aim of this systematic review was to assess the OHRQoL of adult patients under RRT.A systematic literature search was performed using the terms: dialysis […]
• Educational or behavioural interventions for symptoms and health-related quality of life in adults receiving haemodialysis: A systematic review.23rd April 2020
  People with end-stage kidney disease (ESKD) suffer from multiple symptoms, which have a negative impact on their health-related quality of life (HRQoL). Educational and behavioural interventions are being developed for this population; however, the effect of these interventions is unclear.To evaluate the effectiveness of educational or behavioural interventions compared with standard care or alternative strategies […]
• Adapting wellbeing research tools for Aboriginal and Torres Strait Islander people with chronic kidney disease.16th April 2020
  Chronic kidney disease is an increasingly common health problem for Aboriginal and Torres Strait Islander people. It is associated with multiple concurrent psychosocial stressors frequently resulting in negative impacts on emotional and social wellbeing. There is need for well-designed intervention studies to provide evidence of effective treatment for comorbid depression or other mental illness in […]
• Consensus guidelines for management of hyperammonaemia in paediatric patients receiving continuous kidney replacement therapy.10th April 2020
  Hyperammonaemia in children can lead to grave consequences in the form of cerebral oedema, severe neurological impairment and even death. In infants and children, common causes of hyperammonaemia include urea cycle disorders or organic acidaemias. Few studies have assessed the role of extracorporeal therapies in the management of hyperammonaemia in neonates and children. Moreover, consensus […]
• Beta-glucans in advanced CKD: role in endotoxaemia and inflammation.8th April 2020
  (1-3)-β-D glucans (BG) are cellular components of yeasts and fungi. Elevated blood levels may be an adjunct in diagnosing invasive fungal infection, though can be high in dialysis patients without fungaemia. BG can also induce false positive signals in endotoxin detection assays (Limulus Amoebocyte Lysate [LAL] assay). We explored the relationship between BG levels, renal […]
• The risk of bleeding for antiplatelet agents in Haemodialysis patients: a Meta-analysis.29th March 2020
  The safety of antiplatelet therapy in haemodialysis (HD) patients remains controversial. we conducted the first meta-analysis to evaluate the bleeding risk with antiplatelet agents in these populations.The relevant literature was searched using the following electronic databases without any language restrictions: the Cochrane Library, EMBASE, Global Health, MEDLINE, PubMed, and the Chinese Biomedical Database.Seven randomized controlled […]
• Use of the esa resistance index to guide dosing for anaemia management.29th March 2020
  Identifying erythropoiesis-stimulating agent (ESA) resistance is important for treating reversible causes, reaching target haemoglobin levels with minimal dosing, avoiding adverse effects and reducing costs. The resistance index (RI, dose/kg weight/g haemoglobin/dl) is reportedly superior to absolute or weight-based dosing.With the growing number of ESA classes and medications, our goal was to develop methodology to establish […]
• CHANGING NURSING CARE TIME AS AN EFFECT OF CHANGED CHARACTERISTICS OF THE DIALYSIS POPULATION.27th March 2020
  The population of dialysis patients is ageing. Dialysis nurses are confronted with geriatric patients with multiple comorbidities. Nurses are confronted with an increasing burden of care.The present study focused on the question of whether, over time, the increasing age and comorbidities of the haemodialysis population increased nursing care time. Furthermore, we studied potential changes in […]
• The relative importance of frailty, physical and cardiovascular function as exercise-modifiable predictors of falls in haemodialysis patients: a prospective cohort study.15th March 2020
  Stage 5 chronic kidney disease (CKD-5) patients on haemodialysis (HD) are at high risk of accidental falls. Previous research has shown that frailty is one of the primary contributors to the increased risk of falling in this clinical population. However, HD patients often present with abnormalities of cardiovascular function such as baroreflex impairment and orthostatic […]
• Outcomes in acute kidney injury in noncritically ill patients lately referred to nephrologist in a developing country: a comparison of AKIN and KDIGO criteria.13th March 2020
  In low-middle-income countries (LMICs), data regarding acute kidney injury (AKI) are scarce. AKI patients experience delayed diagnosis. This study aimed to evaluate whether delayed nephrologist consultation (NC) affected outcomes of AKI patients and compare Acute Kidney Injury Network (AKIN) and Kidney Disease: Improving Global Outcomes (KDIGO).An observational, retrospective study was conducted in a tertiary public […]
• High dose haemodialysis and haemodiafiltration parameters and the relationship with advanced vascular calcification.8th March 2020
  Vascular calcification (VC) is a risk factor for cardiovascular disease in end-stage renal disease (ESRD) patients undergoing maintenance haemodialysis (MHD). However, evidence is still insufficient about the association between dialysis parameters and VC. Thus, this study was to evaluate association of dialysis parameters with VC.We enrolled 297 ESRD patients undergoing MHD at six distinct centers […]
• Professional relationships between nephrology clinicians and patients: a systematic review.7th March 2020
  Nephrology nurses and patients expressed that the clinician-patient relationship in a haemodialysis (HD) unit might be best described as being part of an extended family. However, there is a risk that professional boundaries may become blurred due to the perceived closeness of this relationship.This systematic review sought to explore the experiences of nephrology clinicians in […]
• Antidepressant Usage in Haemodialysis Patients: Evidence of Sub-Optimal Practice Patterns.14th February 2020
  Depression is common in patients on haemodialysis and associated with adverse outcomes. Antidepressant use is widespread though evidence of efficacy is limited.To study antidepressant management practices in patients on haemodialysis with reference to NICE guidelines on management of depression in adults with chronic physical health problems.Prospective, multicentre, longitudinal cohort study with 6-15 month follow-up.Patients on […]